Trial Profile
A study of the new topical formulation of auriclosene in healthy volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2014
Price :
$35
*
At a glance
- Drugs Auriclosene (Primary)
- Indications Impetigo
- Focus Adverse reactions; Therapeutic Use
- 21 Aug 2014 New trial record
- 10 Jul 2014 NovaBay Pharmaceuticals, along with Galderma, expect to initiate this study before the end of December 2014.